Umathe Sudhir N, Bhutada Pravinkumar S, Jain Nishant S, Dixit Pankaj V, Wanjari Manish M
Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India.
Behav Pharmacol. 2008 Jul;19(4):308-16. doi: 10.1097/FBP.0b013e328308f1fb.
The correlation between neuronal mechanism of anxiety and neuroanatomic expression/neuromodulatory role of gonadotropin-releasing hormone (GnRH), points to a role of GnRH in the modulation of anxiety. Therefore, we investigated the influence of GnRH agonists and antagonist on the anxiety-like behavior of rats in the elevated plus-maze and social interaction tests. GnRH agonists, leuprolide [100 or 200 ng/rat, intracerebroventricularly (i.c.v.)] or 6-D-tryptophan luteinizing hormone-releasing hormone (400 ng/rat, i.c.v.), significantly increased percentage of open arms entries, time spent in open arms, and time spent in social interaction. The observed anxiolytic effect of these agents was comparable with diazepam (0.5-1.0 mg/kg, intraperitoneally). Treatment with a GnRH antagonist [pGlu-D-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2, (100 ng/rat, i.c.v.)], significantly reduced percentage of open arm indices and decreased time spent in social interaction, indicating an anxiogenic-like effect. Further, castrated rats exhibited anxiogenic-like behavior in these tests, which was significantly attenuated by leuprolide (200 ng/rat, i.c.v.) or 6-D-tryptophan luteinizing hormone-releasing hormone (400 ng/rat, i.c.v.), indicating the noninvolvement of peripheral sex hormone in their anxiolytic-like effect, at least in castrated rats. In conclusion, this study indicated a putative role of GnRH in the control of anxiety, and further adds to the importance of investigating the possible role of the hypothalamus-pituitary-gonadal axis in regulating the anxiety-related disorders arising out of hypothalamus-pituitary-adrenal axis dysregulation.
焦虑的神经元机制与促性腺激素释放激素(GnRH)的神经解剖学表达/神经调节作用之间的相关性,表明GnRH在焦虑调节中发挥作用。因此,我们在高架十字迷宫和社交互动试验中研究了GnRH激动剂和拮抗剂对大鼠焦虑样行为的影响。GnRH激动剂亮丙瑞林[100或200 ng/大鼠,脑室内注射(i.c.v.)]或6-D-色氨酸促黄体生成素释放激素(400 ng/大鼠,i.c.v.),显著增加了进入开放臂的百分比、在开放臂中花费的时间以及在社交互动中花费的时间。这些药物观察到的抗焦虑作用与地西泮(0.5 - 1.0 mg/kg,腹腔注射)相当。用GnRH拮抗剂[pGlu-D-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2,(100 ng/大鼠,i.c.v.)]治疗,显著降低了开放臂指数的百分比,并减少了在社交互动中花费的时间,表明具有促焦虑样作用。此外,去势大鼠在这些试验中表现出促焦虑样行为,亮丙瑞林(200 ng/大鼠,i.c.v.)或6-D-色氨酸促黄体生成素释放激素(400 ng/大鼠,i.c.v.)可显著减轻这种行为,表明外周性激素至少在去势大鼠中对其抗焦虑样作用没有参与。总之,本研究表明GnRH在焦虑控制中具有假定作用,并进一步增加了研究下丘脑 - 垂体 - 性腺轴在调节由下丘脑 - 垂体 - 肾上腺轴失调引起的焦虑相关疾病中可能作用的重要性。